| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.24 | 2e-06 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.2 | 4e-05 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.13 | 9e-05 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.18 | 0.0001 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.21 | 0.0002 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0005 |